Skip to main content
. 2018 Nov 29;126(1):246–254. doi: 10.1152/japplphysiol.00804.2018

Fig. 3.

Fig. 3.

Flow-mediated dilation (FMD; A and B), baseline diameter (C and D), and peak diameter (E and F) before and after prolonged occlusion for placebo (A, C, and E) and Montmorency cherry (MC; B, D, and F) conditions. Values are expressed as means ± SE; n = 12. *Significant difference from baseline (main effect for time, P < 0.05). #Condition vs. supplementation vs. time interaction, P < 0.05.